Correlation Between SentinelOne and Nykode Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SentinelOne and Nykode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SentinelOne and Nykode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SentinelOne and Nykode Therapeutics ASA, you can compare the effects of market volatilities on SentinelOne and Nykode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SentinelOne with a short position of Nykode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SentinelOne and Nykode Therapeutics.

Diversification Opportunities for SentinelOne and Nykode Therapeutics

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between SentinelOne and Nykode is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding SentinelOne and Nykode Therapeutics ASA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nykode Therapeutics ASA and SentinelOne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SentinelOne are associated (or correlated) with Nykode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nykode Therapeutics ASA has no effect on the direction of SentinelOne i.e., SentinelOne and Nykode Therapeutics go up and down completely randomly.

Pair Corralation between SentinelOne and Nykode Therapeutics

Taking into account the 90-day investment horizon SentinelOne is expected to generate 0.24 times more return on investment than Nykode Therapeutics. However, SentinelOne is 4.09 times less risky than Nykode Therapeutics. It trades about 0.17 of its potential returns per unit of risk. Nykode Therapeutics ASA is currently generating about -0.16 per unit of risk. If you would invest  2,579  in SentinelOne on September 1, 2024 and sell it today you would earn a total of  216.00  from holding SentinelOne or generate 8.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy91.3%
ValuesDaily Returns

SentinelOne  vs.  Nykode Therapeutics ASA

 Performance 
       Timeline  
SentinelOne 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SentinelOne are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively abnormal basic indicators, SentinelOne unveiled solid returns over the last few months and may actually be approaching a breakup point.
Nykode Therapeutics ASA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nykode Therapeutics ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

SentinelOne and Nykode Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SentinelOne and Nykode Therapeutics

The main advantage of trading using opposite SentinelOne and Nykode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SentinelOne position performs unexpectedly, Nykode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nykode Therapeutics will offset losses from the drop in Nykode Therapeutics' long position.
The idea behind SentinelOne and Nykode Therapeutics ASA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments